Startup · $2.2m raised
Fast-tracks biomedical R&D by enabling scientists to grow 3D cell cultures that model human biology and offer ethical alternatives to animal testing.
Brisbane, QLD
Every investor coverage indicates participated in a round Gelomics raised.
| Investor | Rounds | Invested |
|---|---|---|
| AngelLoop | Seed | - |
| Enterprise Acceleration Fund | Seed | - |
| Jelix Fund 1 | Seed | - |
| Jelix Ventures | Seed | - |
| QIC Ventures | Seed | - |
| Queensland Investment Corporation | Seed | - |
Companies Gelomics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Christoph Meinert | CEO · Founder | Startup Daily (5 Jul 2024), Startup Daily (14 Aug 2023) |
Stories naming Gelomics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Bionic voice device maker Laronix has joined Google's AI First accelerator among ten Australia-New Zealand startups, alongside Presien, Gelomics and Atomic Tessellator; the ten-week program mentors founders building AI products.
Brisbane biotech Gelomics has raised a pre-seed round to advance its animal-free tissue testing technology, with Jelix Ventures leading and QIC's Enterprise Acceleration Fund and Angelloop participating.
Jelix's investment note explains why its fund led Gelomics's seed round, with QIC and Angelloop participating; the startup grows 3D cell cultures for biomedical research and drug development.
Partner content profiling Gelomics, a Brisbane biotech whose 3D tissue culture technology now reaches over 200 labs internationally, crediting a Queensland government export grant with helping it win its first Japanese customers.